Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 1
2014 3
2016 4
2017 4
2018 15
2019 31
2020 23
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean ziyan xu (21 results)?
PM2.5 induced pulmonary fibrosis in vivo and in vitro.
Xu Z, Li Z, Liao Z, Gao S, Hua L, Ye X, Wang Y, Jiang S, Wang N, Zhou D, Deng X. Xu Z, et al. Ecotoxicol Environ Saf. 2019 Apr 30;171:112-121. doi: 10.1016/j.ecoenv.2018.12.061. Epub 2018 Dec 28. Ecotoxicol Environ Saf. 2019. PMID: 30597315
Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β-catenin pathway in NSCLC.
Wang J, Zhou P, Wang X, Yu Y, Zhu G, Zheng L, Xu Z, Li F, You Q, Yang Q, Zhuo W, Sun J, Chen Z. Wang J, et al. Among authors: xu z. Cell Prolif. 2019 May;52(3):e12592. doi: 10.1111/cpr.12592. Epub 2019 Mar 7. Cell Prolif. 2019. PMID: 30848009 Free PMC article.
Concurrent EGFR-TKI and Thoracic Radiotherapy as First-Line Treatment for Stage IV Non-Small Cell Lung Cancer Harboring EGFR Active Mutations.
Zheng L, Wang Y, Xu Z, Yang Q, Zhu G, Liao XY, Chen X, Zhu B, Duan Y, Sun J. Zheng L, et al. Among authors: xu z. Oncologist. 2019 Aug;24(8):1031-e612. doi: 10.1634/theoncologist.2019-0285. Epub 2019 Apr 30. Oncologist. 2019. PMID: 31040256 Free PMC article. Clinical Trial.
Fabrication and evaluation a transferrin receptor targeting nano-drug carrier for cerebral infarction treatment.
Shen J, Zhao Z, Shang W, Liu C, Zhang B, Xu Z, Cai H. Shen J, et al. Among authors: xu z. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):192-200. doi: 10.1080/21691401.2018.1548471. Artif Cells Nanomed Biotechnol. 2019. PMID: 30663409
Overexpression of TIPE2, a Negative Regulator of Innate and Adaptive Immunity, Attenuates Cognitive Deficits in APP/PS1 Mice.
Miao Y, Wang N, Shao W, Xu Z, Yang Z, Wang L, Ju C, Zhang R, Zhang F. Miao Y, et al. Among authors: xu z. J Neuroimmune Pharmacol. 2019 Sep;14(3):519-529. doi: 10.1007/s11481-019-09861-2. Epub 2019 Jul 8. J Neuroimmune Pharmacol. 2019. PMID: 31286344
Impacts of exposure to humidex on the risk of childhood asthma hospitalizations in Hefei, China: Effect modification by gender and age.
Pan R, Gao J, Wang X, Bai L, Wei Q, Yi W, Xu Z, Duan J, Cheng Q, Zhang Y, Su H. Pan R, et al. Among authors: xu z. Sci Total Environ. 2019 Nov 15;691:296-305. doi: 10.1016/j.scitotenv.2019.07.026. Epub 2019 Jul 3. Sci Total Environ. 2019. PMID: 31323575
Hyperprogressive Disease In Cervical Small Cell Carcinoma Treated By Immune Checkpoint Inhibitor.
Xu Z, Chen L, Zheng L, Yang Q, Chen M, Wang J, Zhu G, Chen Z, Sun J. Xu Z, et al. Onco Targets Ther. 2019 Oct 30;12:8873-8877. doi: 10.2147/OTT.S213436. eCollection 2019. Onco Targets Ther. 2019. PMID: 31802899 Free PMC article.
High-Performance Wafer-Scale MoS2 Transistors toward Practical Application.
Xu H, Zhang H, Guo Z, Shan Y, Wu S, Wang J, Hu W, Liu H, Sun Z, Luo C, Wu X, Xu Z, Zhang DW, Bao W, Zhou P. Xu H, et al. Among authors: xu z. Small. 2018 Nov;14(48):e1803465. doi: 10.1002/smll.201803465. Epub 2018 Oct 16. Small. 2018. PMID: 30328296
73 results
Jump to page
Feedback